> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Vote on Ipsen NDA for Palovarotene
- URL: https://www.fdaweb.com/panel-to-vote-on-ipsen-nda-for-palovarotene/
- Published: 2022-08-22T12:00:00.000Z
- Updated: 2026-09-14T17:56:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152556

*Federal Register* notice: FDA has announced a 10/31 Endocrinologic and Metabolic Drugs Advisory Committee meeting. Panel members are scheduled to discuss and vote on an Ipsen Biopharmaceuticals NDA for palovarotene capsules, indicated for preventing heterotopic ossification in adults and children with fibrodysplasia ossificans progressiva. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-18143.pdf?ref=fdaweb.com).